The global single-use assemblies market, valued at US$ 2.52 billion in 2023, is forecasted to grow at a robust CAGR of 13.2%, ...

Single-use technologies in biopharmaceuticals are disposable tools that improve efficiency, reduce contamination, and cut costs. They are becoming popular for producing medicines like vaccines and ...

The global single-use assemblies market, valued at US$ 2.52 billion in 2023, is forecasted to grow at a robust CAGR of 13.2%, reaching US$ 2.63 ...

Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced key changes ...

The global gene transfer technologies market, valued at US$3.63 billion in 2023, is forecasted to grow at a robust CAGR of 9.7%, reaching US$3.73 billion in 2024 and an impressive US$5.93 billion by ...

Robert F. Kennedy Jr. earned millions from his work as an attorney, including referral fees from cases filed against the ...

The cell culture market is estimated to valued at USD 22.56 Bn in 2024 and expected to reach USD 49.39 Bn by 2031, growing at CAGR of 11.8% from 2024 to 2031. BURLINGAME, CA, UNITED STATES ...

(Bloomberg) -- Doctors may change how they treat liver cancer after drugs from AstraZeneca Plc and Merck & Co. helped some patients ... and took Astra’s Imfinzi as well as the Roche Holding AG drug ...

Ozanimod▼ is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS) with active ...